Sort by
Items per page

Send to

Choose Destination

Search results

Items: 6


HIV-1 Drug Resistance and Second-Line Treatment in Children Randomized to Switch at Low Versus Higher RNA Thresholds.

Harrison L, Melvin A, Fiscus S, Saidi Y, Nastouli E, Harper L, Compagnucci A, Babiker A, McKinney R, Gibb D, Tudor-Williams G; PENPACT-1 (PENTA 9PACTG 390) Study Team.

J Acquir Immune Defic Syndr. 2015 Sep 1;70(1):42-53. doi: 10.1097/QAI.0000000000000671.


Using CD4 percentage and age to optimize pediatric antiretroviral therapy initiation.

Yin DE, Warshaw MG, Miller WC, Castro H, Fiscus SA, Harper LM, Harrison LJ, Klein NJ, Lewis J, Melvin AJ, Tudor-Williams G, McKinney RE Jr; PENPACT-1 (PENTA 9/PACTG 390) Study Team.

Pediatrics. 2014 Oct;134(4):e1104-16. doi: 10.1542/peds.2014-0527.


Setting Up a Patient Care Call Center After Potential HCV Exposure.

Friedman C, Bucholz B, Anderson SG, Dwyer SA, Aguirre J.

J Patient Saf. 2016 Sep;12(3):167-70. doi: 10.1097/PTS.0000000000000073.


Selected vaginal bacteria and risk of preterm birth: an ecological perspective.

Wen A, Srinivasan U, Goldberg D, Owen J, Marrs CF, Misra D, Wing DA, Ponnaluri S, Miles-Jay A, Bucholz B, Abbas K, Foxman B.

J Infect Dis. 2014 Apr 1;209(7):1087-94. doi: 10.1093/infdis/jit632. Epub 2013 Nov 22.


Gram stains: a resource for retrospective analysis of bacterial pathogens in clinical studies.

Srinivasan U, Ponnaluri S, Villareal L, Gillespie B, Wen A, Miles A, Bucholz B, Marrs CF, Iyer RK, Misra D, Foxman B.

PLoS One. 2012;7(10):e42898. doi: 10.1371/journal.pone.0042898. Epub 2012 Oct 11.


First-line antiretroviral therapy with a protease inhibitor versus non-nucleoside reverse transcriptase inhibitor and switch at higher versus low viral load in HIV-infected children: an open-label, randomised phase 2/3 trial.

PENPACT-1 (PENTA 9/PACTG 390) Study Team, Babiker A, Castro nee Green H, Compagnucci A, Fiscus S, Giaquinto C, Gibb DM, Harper L, Harrison L, Hughes M, McKinney R, Melvin A, Mofenson L, Saidi Y, Smith ME, Tudor-Williams G, Walker AS.

Lancet Infect Dis. 2011 Apr;11(4):273-83. doi: 10.1016/S1473-3099(10)70313-3. Epub 2011 Jan 31.

Supplemental Content

Loading ...
Support Center